A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 22,200 shares of AKYA stock, worth $71,484. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,200
Previous 50,700 56.21%
Holding current value
$71,484
Previous $238,000 78.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.94 - $4.56 $55,290 - $129,959
-28,500 Reduced 56.21%
22,200 $51,000
Q1 2024

May 13, 2024

BUY
$4.33 - $6.06 $14,289 - $19,998
3,300 Added 6.96%
50,700 $238,000
Q4 2023

Feb 13, 2024

SELL
$3.13 - $5.13 $517,076 - $847,476
-165,200 Reduced 77.7%
47,400 $231,000
Q3 2023

Nov 14, 2023

BUY
$4.24 - $7.44 $140,768 - $247,008
33,200 Added 18.51%
212,600 $989,000
Q2 2023

Aug 11, 2023

BUY
$5.28 - $8.35 $947,232 - $1.5 Million
179,400 New
179,400 $1.33 Million

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $122M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.